Archive

Archive for the ‘Medistem (MEDS.PK)’ Category

Medistem (MEDS) receives Patent Allowance

June 29th, 2012 No comments

Covering the use of fat stem cells, and cells associated with fat stem cells for treatment of diseases related to a dysfunctional immune system Read more…

Categories: Medistem (MEDS.PK)

Medistem (MEDS.PK) and Ercell initiate P2 Recover ERC Heart Failure Trial

January 31st, 2012 No comments

MEDS.PK  together with its Russian licensee, ERCell LLC, successfully dosed 3 heart failure patients Read more…

Categories: Medistem (MEDS.PK)